Rystiggo Side Effects
Generic name: rozanolixizumab
Medically reviewed by Drugs.com. Last updated on Apr 29, 2025.
Note: This document provides detailed information about Rystiggo.
Applies to rozanolixizumab: subcutaneous solution Side Effects associated with rozanolixizumab. Some dosage forms listed on this page may not apply specifically to the brand name Rystiggo.
Applies to rozanolixizumab: subcutaneous solution.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.
This medicine may increase your risk of infection. Check with your doctor right away if you have a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
Check with your doctor if you have fever, headache, nausea, stiff neck or back, or vomiting. These may be symptoms of aseptic meningitis (swelling of the brain).
This medicine may cause serious allergic reaction, including angioedema and rash, which can be life-threatening and require immediate medical attention. Check with your doctor right away if you have large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs.
While you are being treated with rozanolixizumab-noli injection, and after you stop treatment with it, do not have any immunizations (vaccines) without your doctor's approval. Rozanolixizumab-noli may lower your body's resistance and there is a chance you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live virus vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of Rystiggo
Along with its needed effects, rozanolixizumab (the active ingredient contained in Rystiggo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking rozanolixizumab:
More common side effects
- bladder pain
- bloody or cloudy urine
- body aches or pain
- burning or stinging of the skin
- chills
- cough
- difficult, burning, or painful urination
- ear congestion
- fast heartbeat
- fever
- frequent urge to urinate
- headache
- lower back or side pain
- painful cold sores or blisters on the lips, nose, eyes, or genitals
- skin itching, rash, or redness
- sneezing
- sore throat
- stuffy or runny nose
- swelling of the face, throat, or tongue
- trouble breathing
- unusual tiredness or weakness
Incidence not known
- nausea
- stiff neck or back
- vomiting
Other side effects of Rystiggo
Some side effects of rozanolixizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
- diarrhea
- difficulty in moving
- joint pain
- muscle pain or stiffness
- stomach pain
For healthcare professionals
Applies to rozanolixizumab: subcutaneous solution.
General adverse events
Headache, infections, diarrhea, pyrexia, hypersensitivity reactions, and nausea were the prevailing adverse reactions observed in a minimum of 10% of patients who received treatment with this drug.[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (20%), nausea (10%)
- Common (1% to 10%): Abdominal pain[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infections[Ref]
Hypersensitivity
- Very common (10% or more): Hypersensitivity reactions (11%)[Ref]
During clinical trials, hypersensitivity reactions were observed within a range of 1 day to 2 weeks following administration of this drug.
One patient discontinued treatment with this drug due to a hypersensitivity reaction.
Furthermore, local reactions at the site of administration were reported within 1 to 3 days after the most recent infusion of this drug.[Ref]
Local
- Common (1% to 10%): Administration site reactions[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia[Ref]
Nervous system
- Very common (10% or more): Headache (44%)[Ref]
Cases of severe headache were reported in 5.3% of patients.
A patient required hospitalization due to a severe headache, while another patient discontinued treatment as a result of a severe headache accompanied by fever, photophobia, phonophobia, nausea, and vertigo.[Ref]
Other
- Very common (10% or more): Any infection (23%), pyrexia (17%)
- Common (1% to 10%): Herpes simplex[Ref]
Respiratory
- Very common (10% or more): COVID-19 infection (14%)
- Common (1% to 10%): Upper respiratory tract infection[Ref]
Three fatal cases of pneumonia were identified, with two cases attributed to COVID-19 infection and one case caused by an unknown pathogen.[Ref]
See also:
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Vyvgart
Vyvgart is used for myasthenia gravis to improve muscle weakness in adults whose myasthenia gravis ...
Soliris
Soliris infusion is used to treat adults with paroxysmal nocturnal hemoglobinuria (PNH), adults and ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Neostigmine
Neostigmine systemic is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine systemic is used for dysautonomia, myasthenia gravis, nerve agent pretreatment ...
References
1. (2023) "Product Information. Rystiggo (rozanolixizumab)." UCB Pharma Inc
Frequently asked questions
More about Rystiggo (rozanolixizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Rystiggo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.